Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

ClinicalTrials.gov ID: NCT01831765

Public ClinicalTrials.gov record NCT01831765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 7:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of FIAsp (faster-acting insulin aspart) compared to insulin aspart, both in combination with insulin detemir in adults with type 1 diabetes. This trial consists of two periods: a 26 week treatment period followed by a 26 week additional treatment period.

Study identification

NCT ID
NCT01831765
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,290 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 26, 2013 (Actual)
Primary completion
May 12, 2015 (Actual)
Completion
Jun 11, 2015 (Actual)
Last update posted
Jun 12, 2019

2013 – 2015

United States locations

U.S. sites
116
U.S. states
35
U.S. cities
90
Facility City State ZIP Site status
Novo Nordisk Investigational Site Mobile Alabama 36608 —
Novo Nordisk Investigational Site Tucson Arizona 85714 —
Novo Nordisk Investigational Site Tucson Arizona 85724 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Fullerton California 92835 —
Novo Nordisk Investigational Site Inglewood California 90301 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site La Mesa California 91942 —
Novo Nordisk Investigational Site Long Beach California 90807 —
Novo Nordisk Investigational Site North Hollywood California 91606 —
Novo Nordisk Investigational Site Northridge California 91324 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site San Diego California 92037 —
Novo Nordisk Investigational Site Santa Barbara California 93105-4321 —
Novo Nordisk Investigational Site Santa Barbara California 93105 —
Novo Nordisk Investigational Site Ventura California 93003-2824 —
Novo Nordisk Investigational Site Ventura California 93003 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Denver Colorado 80209 —
Novo Nordisk Investigational Site Newark Delaware 19713 —
Novo Nordisk Investigational Site Boca Raton Florida 33433 —
Novo Nordisk Investigational Site Coral Gables Florida 33134 —
Novo Nordisk Investigational Site Fleming Island Florida 32203 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33308 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33312 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Miami Florida 33015 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Miami Florida 33173 —
Novo Nordisk Investigational Site Miami Florida 33174 —
Novo Nordisk Investigational Site Sanford Florida 32771 —
Novo Nordisk Investigational Site Tampa Florida 33614 —
Novo Nordisk Investigational Site Atlanta Georgia 30318 —
Novo Nordisk Investigational Site Atlanta Georgia 30339 —
Novo Nordisk Investigational Site Dunwoody Georgia 30338 —
Novo Nordisk Investigational Site Lawrenceville Georgia 30046 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596 —
Novo Nordisk Investigational Site Nampa Idaho 83686-6011 —
Novo Nordisk Investigational Site Chicago Illinois 60064 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Crystal Lake Illinois 60012 —
Novo Nordisk Investigational Site Springfield Illinois 62711 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site Lenexa Kansas 66219 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Lexington Kentucky 40502 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Portland Maine 04101 —
Novo Nordisk Investigational Site Baltimore Maryland 21204 —
Novo Nordisk Investigational Site Baltimore Maryland 21287 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Waltham Massachusetts 02453 —
Novo Nordisk Investigational Site Worcester Massachusetts 01655 —
Novo Nordisk Investigational Site Kalamazoo Michigan 49048 —
Novo Nordisk Investigational Site Eagan Minnesota 55123 —
Novo Nordisk Investigational Site Minneapolis Minnesota 55416 —
Novo Nordisk Investigational Site Kansas City Missouri 64106 —
Novo Nordisk Investigational Site Springfield Missouri 65807 —
Novo Nordisk Investigational Site Butte Montana 59701 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Henderson Nevada 89052-2649 —
Novo Nordisk Investigational Site Las Vegas Nevada 89128 —
Novo Nordisk Investigational Site Las Vegas Nevada 89148 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Hoboken New Jersey 07030 —
Novo Nordisk Investigational Site Jersey City New Jersey 07306 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87106 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87109-2134 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87131 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site New York New York 10029 —
Novo Nordisk Investigational Site Rochester New York 14607 —
Novo Nordisk Investigational Site Smithtown New York 11787 —
Novo Nordisk Investigational Site Staten Island New York 10301-3901 —
Novo Nordisk Investigational Site Staten Island New York 10301 —
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557 —
Novo Nordisk Investigational Site Columbus Ohio 43201 —
Novo Nordisk Investigational Site Mentor Ohio 44060 —
Novo Nordisk Investigational Site Portland Oregon 97210 —
Novo Nordisk Investigational Site Portland Oregon 97239 —
Novo Nordisk Investigational Site Jenkintown Pennsylvania 19046-3638 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19140-5103 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19140 —
Novo Nordisk Investigational Site Greenville South Carolina 29605-4254 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Amarillo Texas 79106 —
Novo Nordisk Investigational Site Austin Texas 78731 —
Novo Nordisk Investigational Site Beaumont Texas 77701 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Houston Texas 77079 —
Novo Nordisk Investigational Site Houston Texas 77099 —
Novo Nordisk Investigational Site Lubbock Texas 79423 —
Novo Nordisk Investigational Site Plano Texas 75093 —
Novo Nordisk Investigational Site Round Rock Texas 78681 —
Novo Nordisk Investigational Site Sugar Land Texas 77479 —
Novo Nordisk Investigational Site Magna Utah 84044 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Spokane Washington 99201 —
Novo Nordisk Investigational Site Spokane Washington 99202-1334 —
Novo Nordisk Investigational Site Spokane Washington 99202-3649 —
Novo Nordisk Investigational Site Spokane Washington 99202 —
Novo Nordisk Investigational Site Spokane Washington 99208 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01831765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2019 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01831765 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →